Related Experiment Video
Updated: Jun 23, 2026

Primary Outcome Assessment in a Pig Model of Acute Myocardial Infarction
Published on: October 14, 2016
Reverse T3 as a parameter of myocardial function impairment in heart failure
Abstract:
Sick Euthyroid Syndrome (SES) has been defined as low T(3) levels in the presence of normal TSH concentrations. The purpose of this study was to assess the relationship between heart failure functional classes (NYHA) and the presence of SES, as well as to estimate an index of myocardial function impairment (MFI). Forty-six patients were evaluated and 66 clinical laboratory assessments were performed. Clinical laboratory assessment reports (CLAR) were categorized according to heart failure functional class. The levels of rT(3) and fT(3)/rT(3) ratios were significantly higher and lower in class IV, respectively. In all CLAR reviewed, rT(3) positively correlated with functional classes II, III and IV. By adding the mean of the rT3 values found in Group I to one SD, MFI was estimated as 0.47 µg/mL. In 24 of the 66 CLAR reviewed MFI>0.47 µg/mL. Of these 24 CLAR, 92% were in Group II, and 8% were in Group I. MFI was low in 42 CLAR; 74% in Group II and 26% in Group I. MFI and rT(3) levels could be used for the evaluation of the prognosis of patients with heart failure in addition to (or even replacing) NYHA functional classification given that rT(3)>MFI suggests that the patient has a 92% possibility to be in NYHA functional class III or IV.
More Related Videos
08:19Transthoracic Echocardiography to Assess Post-Resuscitation Left Ventricular Dysfunction After Acute Myocardial Infarction and Cardiac Arrest in Pigs
Published on: July 12, 2022
05:07Dynamic Assessments of Coronary Flow Reserve after Myocardial Ischemia Reperfusion in Mice
Published on: August 25, 2023
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Mitral Regurgitation I: Introduction
Heart Failure IV: Classification and Diagnostic Evaluation
Cardiomyopathy II: Dilated Cardiomyopathy
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Mitral Regurgitation III: Medical Management